O logo
O

REALTY INCOME CORP

REALTY INCOME CORP (O) Stock News

The latest O headlines and market coverage — 30 recent stories, updated throughout the day.

  • GlobeNewswire Inc.·Neutral

    Algorhythm Announces CEO Transition in Connection with Transformational Acquisition and Strategic Refocus

    Algorhythm Holdings (NASDAQ: RIME) announced a leadership transition, dismissing CEO Gary Atkinson after 20 years of service. The change follows the company's completion of a corporate transaction involving the acquisition of a high-growth, EBITDA-positive energy infrastructure business focused on data center power generation. A new CEO and board members have been appointed as part of the company's strategic repositioning away from its SemiCab AI logistics business.

  • The Motley Fool·

    3 AI Stocks Poised to Outperform Micron and Sandisk as the Next Infrastructure Bottleneck Builds

    As AI infrastructure demands evolve beyond chips and memory, three companies are positioned to capitalize on emerging bottlenecks: Innodata provides data organization services with 58% revenue growth; Nebius offers neocloud services with expanding data center capacity and rising per-megawatt contract values; and Vertiv supplies critical liquid cooling solutions for AI infrastructure with 24% revenue growth and accelerating demand.

  • GlobeNewswire Inc.·

    Onity Group to Host Its First Investor Day Event on November 19, 2026

    Onity Group Inc. (NYSE: ONIT), a leading non-bank financial services company specializing in mortgage servicing and originations, announced its first Investor Day scheduled for November 19, 2026 in New York. The event will feature presentations from executive leadership, including Chair, President, and CEO Glen Messina, discussing the company's strategy to enhance customer experience, drive operating excellence, and create sustainable growth. In-person attendance is by invitation only, with a live webcast available for remote participants.

  • GlobeNewswire Inc.·

    Immunotherapy Drugs Market 2026: Precision Medicine, Next-Generation Biologics and Expanding Cancer Indications Fuel Growth Opportunities

    The global immunotherapy drugs market is experiencing significant growth driven by advances in biotechnology, rising demand for targeted treatments, and expanding therapeutic applications across cancer, autoimmune, and inflammatory diseases. Key growth factors include increasing disease burden, robust drug pipelines, personalized medicine adoption, and combination therapy development. The Americas and Europe remain dominant markets, while Asia-Pacific is emerging as a high-growth region. Major pharmaceutical and biotech companies are increasing R&D investments and collaboration to accelerate innovation.

  • Zacks Investment Research·

    Should Invesco S&P SmallCap Momentum ETF (XSMO) Be on Your Investing Radar?

    The Invesco S&P SmallCap Momentum ETF (XSMO) offers exposure to small-cap growth stocks with $2.91 billion in assets and a 0.36% expense ratio. The ETF has returned 14.62% year-to-date and 13.13% over the past year, with a beta of 1.08 and 109 holdings. It carries a Zacks ETF Rank of 3 (Hold), positioning it as a sufficient option for small-cap growth investors, though competitors like Vanguard Morningstar Small-Cap Growth ETF (VBK) offer lower expense ratios.

  • Zacks Investment Research·

    Is Northern Trust Credit-Scored US Corporate Bond ETF (SKOR) a Strong ETF Right Now?

    The Northern Trust Credit-Scored US Corporate Bond ETF (SKOR) is a smart beta ETF with $756.16 million in assets and a 0.15% expense ratio. Year-to-date performance is -0.75%, with a 12-month return of 0.38%. The fund carries higher risk with a beta of 0.22 and standard deviation of 3.54%. Cheaper alternatives like SPIB and VCIT are recommended for investors seeking lower-cost, lower-risk options.

  • GlobeNewswire Inc.·

    Tower Semiconductor to Highlight its High-Volume Silicon Photonics and SiGe Solutions for AI Infrastructure, Telecom and Emerging Applications at ECOC 2026

    Tower Semiconductor announced its participation in ECOC 2026 (September 21-23 in Malaga, Spain) where it will showcase its silicon photonics platform and SiGe BiCMOS solutions for AI infrastructure, datacenter, telecom, and emerging applications including near/co-packaged optics, DWDM lasers, optical circuit switching, and quantum computing.

  • GlobeNewswire Inc.·Neutral

    Teaching Old Apps New Tricks with Advanced Conversational AI

    Jitterbit announced new conversational AI capabilities for its App Builder that enable organizations to embed AI agents directly into applications, eliminating front-end coding and reducing enterprise AI deployment time. The company also introduced a Management AI Assistant in beta for platform administrators and expanded its Jitterbit Marketplace with new autonomous AI agents across sales, marketing, operations, and HR functions.

  • GlobeNewswire Inc.·

    Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics

    The global oligonucleotide therapeutics market is projected to grow from USD 7.7 billion in 2025 to USD 72.1 billion by 2035, expanding at a 23.4% CAGR. Growth is driven by advances in RNA-based medicine, targeted delivery technologies, expanding applications beyond rare diseases into chronic and metabolic conditions, and increasing regulatory approvals. Antisense oligonucleotides lead the market at 39.9% share, while subcutaneous administration dominates at 56.4%. North America commands 57.9% market share.

  • GlobeNewswire Inc.·

    China Mineral Processing Equipment Market Poised for Growth Through 2035 as Mining Modernization, Automation and Energy-Efficient Technologies Create New Opportunities

    China's mineral processing equipment market is projected to grow from USD 8.50 billion in 2025 to USD 13.55 billion by 2035, driven by EV supply chains, critical mineral processing, automation, and digitalization. Key growth areas include separation equipment for lithium, cobalt, and nickel processing, with regional hubs in Shandong, Jiangxi, and Inner Mongolia leading demand.

  • The Motley Fool·

    SpaceX Is Trading Near Its Opening-Day Price Again. Forecasts Say a $5,000 Investment Will Be Worth This Much in 1 Year.

    SpaceX stock has returned to its opening-day price of ~$150 after a volatile ride since its June 2026 IPO. Analyst price targets range from $75 to $800, with a median target of $217 (43.5% upside potential) over the next 12 months. The company remains unprofitable but shows strong revenue growth and significant AI division investments, making it suitable only for aggressive investors.

  • GlobeNewswire Inc.·

    L’offre du groupement Atos, Open, Thales sélectionnée par l'UGAP pour ses marchés de prestations cloud et infrastructures

    A consortium of Atos, Open, and Thales has been selected by UGAP (France's leading public procurement central) to provide cloud services (PEC) and IT infrastructure services (EIR) for four years. The grouping will serve French public sector clients including ministries, local authorities, and public institutions, with Atos leading the cloud services lot and Open leading the infrastructure lot, while Thales contributes cybersecurity and digital sovereignty expertise.

  • GlobeNewswire Inc.·Neutral

    Sysco Announces Pricing of Common Stock Offering

    Sysco Corporation announced the pricing of a public offering of 12,345,679 shares at $81 per share, expected to close on September 16, 2026. The company intends to use net proceeds to finance its pending acquisition of Jetro Restaurant Depot. Goldman Sachs and TD Securities are lead book-running managers for the offering.

  • The Motley Fool·

    Nike's Chief Legal Officer Sells 3,646 Shares as the Stock Falls to a 52-Week Low

    Nike's Chief Legal Officer Robert Leinwand sold 3,646 shares worth approximately $137,053 on September 9, 2026, as part of a pre-established Rule 10b5-1 trading plan. The sale occurred amid Nike's significant struggles, including a 49% stock decline over the past year, driven by an 11% sales drop in China, flat full-year results, and removal from the S&P 100. Despite the sale, Leinwand maintains a substantial equity position of 89,265 shares, demonstrating continued alignment with shareholder interests.

  • The Motley Fool·

    3 AI Robotics Stocks Worth Owning Over Tesla Right Now

    The article argues that Tesla's valuation is heavily dependent on uncertain humanoid robot commercialization timelines and lofty valuations, making it riskier than alternatives. Instead, investors should consider Nvidia (which supplies chips to all robotics companies), Alphabet (with Google Cloud and Waymo autonomous vehicles), and Zebra Technologies (providing foundational software for robots), all trading at more attractive valuations with more certain growth catalysts.

  • The Motley Fool·

    Why Micron, Intel, AMD, and Other Chip Stocks Fell Today

    Chip stocks including Micron, Intel, AMD, and Nvidia declined following mounting concerns from AI researchers and industry leaders about unchecked AI advancement risks. Anthropic CEO Dario Amodei and other tech leaders are calling for slower AI development and stronger safety standards. A slowdown in AI capabilities advancement could reduce demand for memory chips and AI accelerators, pressuring these semiconductor companies' growth and pricing power.

  • The Motley Fool·

    Forget Picking One Winner: Portfolio Diversification Is the Real Edge, and the Stock Advisor Scorecard Proves It

    The article argues that portfolio diversification is more important than picking individual winning stocks. It highlights how The Motley Fool Stock Advisor achieved 950% returns with a diversified 50+ stock portfolio, and demonstrates that the S&P 500 index has delivered over 400% gains since 2000 through diversification across sectors. The article recommends investors can easily achieve diversification through low-cost S&P 500 ETFs rather than individual stock picking.

  • Reuters·Neutral

    Asian shares waver as oil and yields rise ahead of Fed, BOJ meetings - Reuters

    Asian shares waver as oil and yields rise ahead of Fed, BOJ meetings  Reuters

  • GlobeNewswire Inc.·Neutral

    CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)

    Impact Biomedical Inc (NYSE: IBO) announced a 1 for 12.62 reverse stock split effective September 23, 2026, to support its proposed merger with Zoar Limited. The merger exchange ratio was corrected to 1 share of Zoar for every 1 share of Impact stock (post-split). Upon completion, the combined entity will focus on developing and supplying Active Pharmaceutical Ingredients for special therapeutic areas.

  • GlobeNewswire Inc.·

    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages York Space Systems Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – YSS

    Rosen Law Firm has filed class action lawsuits on behalf of investors in York Space Systems Inc. (YSS), alleging the company made materially false statements about its satellite software functionality and misled the Pentagon's Space Development Agency. The lawsuit covers purchases during the IPO in January 2026 and subsequent trading through May 2026. Investors have until October 30, 2026 to move to become lead plaintiffs.

  • GlobeNewswire Inc.·

    Five Star Bancorp Deepens Community Commitment with Appointment of Lydia Ramirez as Chief External Affairs Officer

    Five Star Bancorp announced the appointment of Lydia Ramirez as Executive Vice President and Chief External Affairs Officer, a newly created role. Ramirez will lead the bank's enterprise-wide external affairs strategy and serve as a connection between the bank, clients, and community partners across California. The appointment reflects Five Star's commitment to responsible growth and community engagement as it continues expanding across the state.

  • Zacks Investment Research·

    Why Onto Innovation (ONTO) Dipped More Than Broader Market Today

    Onto Innovation (ONTO) fell 11.07% in recent trading, underperforming the broader market. Despite the decline, the semiconductor equipment maker received a Zacks Rank #1 (Strong Buy) rating, supported by strong earnings growth projections of 146.74% EPS growth and 79.05% revenue growth for the upcoming quarter. The company's Forward P/E of 34.98 aligns with industry averages, and its PEG ratio of 0.92 suggests reasonable valuation relative to growth expectations.

  • Zacks Investment Research·

    Roku (ROKU) Ascends While Market Falls: Some Facts to Note

    Roku (ROKU) closed at $157.45, up 1.63%, outperforming the broader market declines. The company is expected to report strong earnings growth of 243.75% EPS and 16.49% revenue growth. With a Zacks Rank #1 (Strong Buy) rating and positive estimate revisions, analysts show confidence in the company's near-term performance, though the stock trades at a premium valuation with a Forward P/E of 55.75 compared to its industry average of 11.11.

  • Zacks Investment Research·

    ARKO Corp. (ARKO) Increases Despite Market Slip: Here's What You Need to Know

    ARKO Corp. rose 1.11% to $4.57 on September 14, 2026, outperforming a broader market decline. However, the stock has depreciated 6.8% over the past month. While the company is expected to report a 20% EPS increase for the upcoming quarter, full-year earnings are projected to decline 26.67%. ARKO carries a Zacks Rank of #5 (Strong Sell) with a Forward P/E ratio of 41.09, significantly above its industry average of 18.63.

  • Zacks Investment Research·

    Riot Platforms, Inc. (RIOT) Declines More Than Market: Some Information for Investors

    Riot Platforms (RIOT) closed at $20.95, down 2.42%, underperforming the S&P 500's 0.48% loss. While the stock gained 12.91% over the past month, analysts project a significant earnings decline with EPS expected at -$0.33 (down 226.92% year-over-year) and revenue declining 9.7% to $162.75 million. The company received a Zacks Rank #4 (Sell) rating, with consensus EPS estimates revised 7.29% lower over the last 30 days.

  • Zacks Investment Research·Neutral

    Why Gold.com (GOLD) Dipped More Than Broader Market Today

    Gold.com (GOLD) declined 1.87% in recent trading, underperforming the S&P 500's 0.48% loss. Despite a 9.59% monthly gain, the stock carries a Zacks Rank #3 (Hold) rating. Analysts project 340% EPS growth for the upcoming quarter but anticipate annual earnings to decline 27.29% year-over-year. The stock trades at a Forward P/E of 12.93, above its industry average of 11.74.

  • Zacks Investment Research·Neutral

    Modine (MOD) Sees a More Significant Dip Than Broader Market: Some Facts to Know

    Modine Manufacturing ended trading down 3.76%, outpacing the broader market decline. Despite the recent pullback, the company shows strong growth prospects with expected EPS growth of 37.74% and revenue growth of 30.55% for the upcoming quarter. However, the stock trades at a premium valuation with a Forward P/E of 24.75 versus its industry average of 13.28, and holds a Zacks Rank #3 (Hold) rating.

  • Zacks Investment Research·Neutral

    Altria (MO) Advances While Market Declines: Some Information for Investors

    Altria (MO) outperformed the broader market on September 14, 2026, closing up 2.4% while the S&P 500 declined 0.48%. The stock has gained 4.99% over the past month. Upcoming Q3 earnings are expected on October 29, 2026, with projected EPS of $1.5 (up 3.45% YoY) and revenue of $5.33 billion (up 1.49% YoY). The company holds a Zacks Rank #3 (Hold) with a Forward P/E of 12.16, trading at a discount to its industry average of 14.21.

  • Zacks Investment Research·

    Why the Market Dipped But SoFi Technologies, Inc. (SOFI) Gained Today

    While major market indices declined on September 14, 2026, SoFi Technologies (SOFI) gained 1.91% to close at $17.65. The stock outperformed the broader market despite the S&P 500 falling 0.48%. Analysts expect strong earnings growth with EPS projected at $0.17 (up 54.55% YoY) and revenue of $1.24 billion (up 31.08% YoY). However, SOFI trades at a premium valuation with a Forward P/E of 28.73 versus its industry average of 11.74, and currently holds a Zacks Rank of #3 (Hold).

  • Zacks Investment Research·Neutral

    Coca-Cola (KO) Ascends While Market Falls: Some Facts to Note

    Coca-Cola (KO) closed at $89.35, up 1.2% and outperforming the S&P 500. The company projects Q3 EPS of $0.87 (+6.10% YoY) and full-year earnings of $3.29 per share (+9.67% YoY). However, the stock trades at a Forward P/E of 26.82, significantly above its industry average of 17.93, and carries a PEG ratio of 3.44 versus the industry average of 1.66. Coca-Cola holds a Zacks Rank of #3 (Hold).

Showing 10 of 30 O stories

Including: "Algorhythm Announces CEO Transition in Connection with Transformational Acquisition and Strategic Refocus"

Sign up free to see all 30 + get insider-buy alerts.

Sign up free →